PolyPeptide Group AG (PPGN.SW)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Juan Jose Gonzalez | Chief Executive Officer | 1.39M | -- | 1972 |
| Mr. Marc Augustin | Chief Financial Officer | -- | -- | 1972 |
| Mr. Jens Fricke | Director of Global Operations | -- | -- | 1965 |
| Rene Vestergaard | Director of Corporate Finance | -- | -- | -- |
| Mr. Olivier Ludemann-Hombourger | Director of Global Innovation & Technology | -- | -- | 1972 |
| Mr. Michael Staheli | Head of Investor Relations & Corporate Communications | -- | -- | 1965 |
| Ms. Christina Del Vecchio | Chief Legal Officer & Corporate Secretary | -- | -- | 1978 |
| Andreas Liese | Corporate Compliance Manager | -- | -- | -- |
| Trishul Shah MS | Interim Director Global Sales & Marketing | -- | -- | -- |
| Ms. Monika Casanova | Chief Human Resources Officer | -- | -- | 1979 |
PolyPeptide Group AG
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 1,362
Description
PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, and India. It develops and manufactures synthetic peptides and oligonucleotides used as active pharmaceutical ingredients or intermediates in therapeutic products for pharmaceutical and biotech companies. The company offers portfolio of drug therapies for metabolic diseases, including the GLP-1. It also provides generic peptides and peptides used in cosmetics, animal health, and medical devices. PolyPeptide Group AG was founded in 1952 and is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.
Corporate Governance
Upcoming Events
March 11, 2025 at 6:00 AM UTC
PolyPeptide Group AG Earnings Date
Recent Events
May 2, 2022 at 12:00 AM UTC
Dividend Date
April 28, 2022 at 12:00 AM UTC
Ex-Dividend Date